APA (Adapted Physical Activity) for Patients With Advanced Melanoma
ConditionMelanoma of Skin
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Rouen
About this trial
APA (adapted physical activity) for patients with advanced melanoma APA (adapted physical activity) for patients with advanced melanoma undergoing treatment: evaluation of a personalized program at the hospital Melanoma is a malignant tumor developed from melanocytes. It accounts for approximately 4% of all incident cancers and 1.2% of cancer deaths, regardless of sex.
Since 2011, the advent of new therapies (targeted therapies and immunotherapies) has revolutionized the management of advanced-stage melanoma (unresectable stage III or stage IV).
These treatments have led to a significant improvement in the prognosis of metastatic melanoma, with a 5-year overall survival rate of 34% for targeted therapies, 44% for monotherapy with immunotherapy, and 52% for the combination of nivolumab + ipilimumab.
Due to the improvement in survival rates, advanced melanoma has become a chronic disease affecting all ages. It is therefore essential to maintain the quality of life for these patients.
Eligibility criteria
Qualifiers
Male or female patient aged 18 or older
Advanced melanoma treated adjuvantly or curatively with immunotherapy or targeted therapy
Patient who has read and understood the information letter and does not object to participating in the study
Member of or beneficiary of a social security scheme
Disqualifiers
Minor patient
Melanoma not requiring systemic treatment
Condition making 6-month follow-up impossible
Protected incapacitated persons (judicial protection, guardianship, curatorship, deprivation of liberty)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov